Jun 18 |
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
May 29 |
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
|
May 15 |
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
|
May 15 |
Virpax Announces Pricing of $2.25 Million Public Offering
|
May 14 |
Virpax Pharmaceuticals GAAP EPS of -$2.75
|
May 13 |
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
|
Apr 30 |
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
|
Mar 26 |
Virpax Pharmaceuticals Reports 2023 Year-End Results
|
Feb 7 |
Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
|